Observational studyDrug design, development and therapy2020

Long-Term Safety of a Novel Angiotensin Receptor Blocker, Fimasartan, According to the Absence or Presence of Underlying Liver Disease in Korean Hypertensive Patients: A Prospective, 12-Month, Observational Study.

Gyu Chul Oh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.